Profile
Fabrizio Giannotta is the founder and had held the position of Chief Executive Officer at ProGenosis SA from 2009 to 2011.
He founded ProGenosis SA in 2006.
He received a doctorate degree from the University of Liege in 1998.
Former positions of Fabrizio Giannotta
| Companies | Position | End |
|---|---|---|
ProGenosis SA
 ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Chief Executive Officer | - |
Training of Fabrizio Giannotta
| University of Liege | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
ProGenosis SA
ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
- Stock Market
- Insiders
- Fabrizio Giannotta
